Review




Structured Review

STEMCELL Technologies Inc easy sep human nk cell enrichment kit
Easy Sep Human Nk Cell Enrichment Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/easy sep human nk cell enrichment kit/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
easy sep human nk cell enrichment kit - by Bioz Stars, 2026-03
90/100 stars

Images



Similar Products

90
STEMCELL Technologies Inc easy sep human nk cell enrichment kit
Easy Sep Human Nk Cell Enrichment Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/easy sep human nk cell enrichment kit/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
easy sep human nk cell enrichment kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc easy sep negative selection human nk cells enrichment kit
Easy Sep Negative Selection Human Nk Cells Enrichment Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/easy sep negative selection human nk cells enrichment kit/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
easy sep negative selection human nk cells enrichment kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc human nk cells easy sep kit
Human Nk Cells Easy Sep Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human nk cells easy sep kit/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
human nk cells easy sep kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc easy-sep human nk cell enrichment kit
(A) Freshly purified <t>NK</t> <t>cells</t> (HD n=12; MD n=5) were stimulated with 200U/ml of IL-2. Expression of IL-2R (α chain), IFNγ production, and cytotoxicty were monitored every two days over 6 days (day 0, 2, 4 and 6) by flow cytometry. (B) The percentage of Lamp-1+ NK cells from healthy (n=30) and melanoma donors (n=12) after a cytotoxic assay is shown using K562 cells as target cells (upper left panel). The percentage of IFNγ+ NK cells from healthy (n=22) and melanoma donors (n=9) is shown after 4h stimulation with IL-12 (middle left panel). The percentage of proliferating NK cells from healthy (n=10) and melanoma donors (n=7) is shown after 6 days of culture in presence of 200U/ml of IL-2 (lower left panel). On the right panel of each graph, plots depicting the expression of Lamp-1, IFNγ, and CFSE in NK cells purified from a representative healthy donor and a representative melanoma patient are shown. (C) Graphs representing the MFI of T-bet and Eomes on NK cells purified from healthy (n=19) and melanoma donors (n=14). Representative plots are shown (Isotype control: black; HD: unfilled; MD: gray). All experiments were performed in duplicate.
Easy Sep Human Nk Cell Enrichment Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/easy-sep human nk cell enrichment kit/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
easy-sep human nk cell enrichment kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc easy sep negative-selection human nk cell enrichment kit
(A) Freshly purified <t>NK</t> <t>cells</t> (HD n=12; MD n=5) were stimulated with 200U/ml of IL-2. Expression of IL-2R (α chain), IFNγ production, and cytotoxicty were monitored every two days over 6 days (day 0, 2, 4 and 6) by flow cytometry. (B) The percentage of Lamp-1+ NK cells from healthy (n=30) and melanoma donors (n=12) after a cytotoxic assay is shown using K562 cells as target cells (upper left panel). The percentage of IFNγ+ NK cells from healthy (n=22) and melanoma donors (n=9) is shown after 4h stimulation with IL-12 (middle left panel). The percentage of proliferating NK cells from healthy (n=10) and melanoma donors (n=7) is shown after 6 days of culture in presence of 200U/ml of IL-2 (lower left panel). On the right panel of each graph, plots depicting the expression of Lamp-1, IFNγ, and CFSE in NK cells purified from a representative healthy donor and a representative melanoma patient are shown. (C) Graphs representing the MFI of T-bet and Eomes on NK cells purified from healthy (n=19) and melanoma donors (n=14). Representative plots are shown (Isotype control: black; HD: unfilled; MD: gray). All experiments were performed in duplicate.
Easy Sep Negative Selection Human Nk Cell Enrichment Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/easy sep negative-selection human nk cell enrichment kit/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
easy sep negative-selection human nk cell enrichment kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
STEMCELL Technologies Inc easy sep negative selection human nk cell enrichment kit
(A) Freshly purified <t>NK</t> <t>cells</t> (HD n=12; MD n=5) were stimulated with 200U/ml of IL-2. Expression of IL-2R (α chain), IFNγ production, and cytotoxicty were monitored every two days over 6 days (day 0, 2, 4 and 6) by flow cytometry. (B) The percentage of Lamp-1+ NK cells from healthy (n=30) and melanoma donors (n=12) after a cytotoxic assay is shown using K562 cells as target cells (upper left panel). The percentage of IFNγ+ NK cells from healthy (n=22) and melanoma donors (n=9) is shown after 4h stimulation with IL-12 (middle left panel). The percentage of proliferating NK cells from healthy (n=10) and melanoma donors (n=7) is shown after 6 days of culture in presence of 200U/ml of IL-2 (lower left panel). On the right panel of each graph, plots depicting the expression of Lamp-1, IFNγ, and CFSE in NK cells purified from a representative healthy donor and a representative melanoma patient are shown. (C) Graphs representing the MFI of T-bet and Eomes on NK cells purified from healthy (n=19) and melanoma donors (n=14). Representative plots are shown (Isotype control: black; HD: unfilled; MD: gray). All experiments were performed in duplicate.
Easy Sep Negative Selection Human Nk Cell Enrichment Kit, supplied by STEMCELL Technologies Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/easy sep negative selection human nk cell enrichment kit/product/STEMCELL Technologies Inc
Average 90 stars, based on 1 article reviews
easy sep negative selection human nk cell enrichment kit - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


(A) Freshly purified NK cells (HD n=12; MD n=5) were stimulated with 200U/ml of IL-2. Expression of IL-2R (α chain), IFNγ production, and cytotoxicty were monitored every two days over 6 days (day 0, 2, 4 and 6) by flow cytometry. (B) The percentage of Lamp-1+ NK cells from healthy (n=30) and melanoma donors (n=12) after a cytotoxic assay is shown using K562 cells as target cells (upper left panel). The percentage of IFNγ+ NK cells from healthy (n=22) and melanoma donors (n=9) is shown after 4h stimulation with IL-12 (middle left panel). The percentage of proliferating NK cells from healthy (n=10) and melanoma donors (n=7) is shown after 6 days of culture in presence of 200U/ml of IL-2 (lower left panel). On the right panel of each graph, plots depicting the expression of Lamp-1, IFNγ, and CFSE in NK cells purified from a representative healthy donor and a representative melanoma patient are shown. (C) Graphs representing the MFI of T-bet and Eomes on NK cells purified from healthy (n=19) and melanoma donors (n=14). Representative plots are shown (Isotype control: black; HD: unfilled; MD: gray). All experiments were performed in duplicate.

Journal: Cancer immunology research

Article Title: Reversal of NK cell exhaustion in advanced melanoma by Tim-3 blockade

doi: 10.1158/2326-6066.CIR-13-0171

Figure Lengend Snippet: (A) Freshly purified NK cells (HD n=12; MD n=5) were stimulated with 200U/ml of IL-2. Expression of IL-2R (α chain), IFNγ production, and cytotoxicty were monitored every two days over 6 days (day 0, 2, 4 and 6) by flow cytometry. (B) The percentage of Lamp-1+ NK cells from healthy (n=30) and melanoma donors (n=12) after a cytotoxic assay is shown using K562 cells as target cells (upper left panel). The percentage of IFNγ+ NK cells from healthy (n=22) and melanoma donors (n=9) is shown after 4h stimulation with IL-12 (middle left panel). The percentage of proliferating NK cells from healthy (n=10) and melanoma donors (n=7) is shown after 6 days of culture in presence of 200U/ml of IL-2 (lower left panel). On the right panel of each graph, plots depicting the expression of Lamp-1, IFNγ, and CFSE in NK cells purified from a representative healthy donor and a representative melanoma patient are shown. (C) Graphs representing the MFI of T-bet and Eomes on NK cells purified from healthy (n=19) and melanoma donors (n=14). Representative plots are shown (Isotype control: black; HD: unfilled; MD: gray). All experiments were performed in duplicate.

Article Snippet: NK cell enrichment was performed by negative selection using Easy-Sep Human NK cell Enrichment Kit (StemCell Technologies) according to the manufacturer's recommendations, obtaining more than 95% CD3 − CD56 + populations.

Techniques: Purification, Expressing, Flow Cytometry, Control

(A) The percentage of LAMP-1+ (n=8) and (B) the MFI of IFNγ+ cells (n=6) of NK cells from melanoma donors pre-incubated with IgG-coated beads or anti-Tim-3-coated beads for 2h prior to evaluating the cytotoxic function or IFNγ production. (C) Reverse-ADCC assay using FcR+ P815 cells. NK cells from melanoma or healthy donors were co-cultured with P815 cells and different antibodies were added to the reaction: anti-Tim-3, anti-CD94 (negative control) or anti-CD16 (positive control). Data were normalized to the values obtained for the condition: (A and B) with IgG-coated beads (100%); (C) with no antibody. All experiments were performed in duplicate.

Journal: Cancer immunology research

Article Title: Reversal of NK cell exhaustion in advanced melanoma by Tim-3 blockade

doi: 10.1158/2326-6066.CIR-13-0171

Figure Lengend Snippet: (A) The percentage of LAMP-1+ (n=8) and (B) the MFI of IFNγ+ cells (n=6) of NK cells from melanoma donors pre-incubated with IgG-coated beads or anti-Tim-3-coated beads for 2h prior to evaluating the cytotoxic function or IFNγ production. (C) Reverse-ADCC assay using FcR+ P815 cells. NK cells from melanoma or healthy donors were co-cultured with P815 cells and different antibodies were added to the reaction: anti-Tim-3, anti-CD94 (negative control) or anti-CD16 (positive control). Data were normalized to the values obtained for the condition: (A and B) with IgG-coated beads (100%); (C) with no antibody. All experiments were performed in duplicate.

Article Snippet: NK cell enrichment was performed by negative selection using Easy-Sep Human NK cell Enrichment Kit (StemCell Technologies) according to the manufacturer's recommendations, obtaining more than 95% CD3 − CD56 + populations.

Techniques: Incubation, ADCC Assay, Cell Culture, Negative Control, Positive Control

(A) Graph represents the expression of LAMP-1 (n=15; MFI) in NK cells from melanoma donors incubated with 10 or 20μg/ml of soluble Tim-3 blocking antibody 1h before the cytotoxic assay. (B) Plot shows the percentage of CFSE+7AAD+ K562 cells (% of killed K562 cells) in the presence of 10μg/ml of two different Tim-3 blocking antibodies (clone 2E2 or R&D #AF2365) 1h before the killing assay (n=9 MD). Graphs represent the expression of (C) IFNγ (n=12; MFI) and (D) the percentage of proliferating cells (n=10; %) in NK cells from melanoma donors incubated with 10 or 20μg/ml of soluble Tim-3 blocking antibody 1h before the functional assays. (A, C and D) Plots depicting the expression of LAMP-1, IFNγ production and proliferation with (right panel) and without (middle panel) Tim-3 blockade from a representative melanoma patient. Data were normalized to the values obtained for the condition without blocking antibody. All experiments were performed in duplicate.

Journal: Cancer immunology research

Article Title: Reversal of NK cell exhaustion in advanced melanoma by Tim-3 blockade

doi: 10.1158/2326-6066.CIR-13-0171

Figure Lengend Snippet: (A) Graph represents the expression of LAMP-1 (n=15; MFI) in NK cells from melanoma donors incubated with 10 or 20μg/ml of soluble Tim-3 blocking antibody 1h before the cytotoxic assay. (B) Plot shows the percentage of CFSE+7AAD+ K562 cells (% of killed K562 cells) in the presence of 10μg/ml of two different Tim-3 blocking antibodies (clone 2E2 or R&D #AF2365) 1h before the killing assay (n=9 MD). Graphs represent the expression of (C) IFNγ (n=12; MFI) and (D) the percentage of proliferating cells (n=10; %) in NK cells from melanoma donors incubated with 10 or 20μg/ml of soluble Tim-3 blocking antibody 1h before the functional assays. (A, C and D) Plots depicting the expression of LAMP-1, IFNγ production and proliferation with (right panel) and without (middle panel) Tim-3 blockade from a representative melanoma patient. Data were normalized to the values obtained for the condition without blocking antibody. All experiments were performed in duplicate.

Article Snippet: NK cell enrichment was performed by negative selection using Easy-Sep Human NK cell Enrichment Kit (StemCell Technologies) according to the manufacturer's recommendations, obtaining more than 95% CD3 − CD56 + populations.

Techniques: Expressing, Incubation, Blocking Assay, Functional Assay

(A) Plot depicting the decrease of Tim-3 expression in the membrane of NK cells after 1h treatment with soluble Tim-3 blocking antibody. (B) Graph represents the MFI of NK cells positive for the PE-conjugated, anti-mouse IgG antibody, with or without permeabilization (n=6). (C) The previous experiment was repeated also including an isotype control. Graph shows the percentage of cells positive for the PE-conjugated, anti-mouse IgG antibody after 1h of incubation with antibodies (n=6). (D) The represents the MFI of Lamp-1+ NK cells from healthy donors (n=6) after a cytotoxic assay with K562 cells. (Left panel) NK cells were pre-incubated (2h) with anti-Tim-3-coated beads or IgG-coated beads. (Right panel) Soluble Tim-3 blocking antibody was added 1h before crosslinking with anti-Tim-3-coated beads as described previously. Data were normalized to the values obtained for the condition with beads alone. (E) The plots show the expression of IL-2R α and γ chains (% of positive cells) in NK cells untreated or after 1h of treatment with 10μg/ml of soluble Tim-3 blocking antibody (n=7). Data were normalized to the values obtained for the condition without blocking antibody. (F) The graph depicts the percentage of Lamp-1+ NK cells after two days of culture with 200U/mL of IL-2, untreated or treated with blocking antibody for α, β or β chain (n=5). All experiments were performed in duplicate.

Journal: Cancer immunology research

Article Title: Reversal of NK cell exhaustion in advanced melanoma by Tim-3 blockade

doi: 10.1158/2326-6066.CIR-13-0171

Figure Lengend Snippet: (A) Plot depicting the decrease of Tim-3 expression in the membrane of NK cells after 1h treatment with soluble Tim-3 blocking antibody. (B) Graph represents the MFI of NK cells positive for the PE-conjugated, anti-mouse IgG antibody, with or without permeabilization (n=6). (C) The previous experiment was repeated also including an isotype control. Graph shows the percentage of cells positive for the PE-conjugated, anti-mouse IgG antibody after 1h of incubation with antibodies (n=6). (D) The represents the MFI of Lamp-1+ NK cells from healthy donors (n=6) after a cytotoxic assay with K562 cells. (Left panel) NK cells were pre-incubated (2h) with anti-Tim-3-coated beads or IgG-coated beads. (Right panel) Soluble Tim-3 blocking antibody was added 1h before crosslinking with anti-Tim-3-coated beads as described previously. Data were normalized to the values obtained for the condition with beads alone. (E) The plots show the expression of IL-2R α and γ chains (% of positive cells) in NK cells untreated or after 1h of treatment with 10μg/ml of soluble Tim-3 blocking antibody (n=7). Data were normalized to the values obtained for the condition without blocking antibody. (F) The graph depicts the percentage of Lamp-1+ NK cells after two days of culture with 200U/mL of IL-2, untreated or treated with blocking antibody for α, β or β chain (n=5). All experiments were performed in duplicate.

Article Snippet: NK cell enrichment was performed by negative selection using Easy-Sep Human NK cell Enrichment Kit (StemCell Technologies) according to the manufacturer's recommendations, obtaining more than 95% CD3 − CD56 + populations.

Techniques: Expressing, Membrane, Blocking Assay, Control, Incubation

(A) Graphs compare the expression of the inhibitory receptors KIR3DL1 (HD n=18; MD n=8) and KIR2DL3 (HD n=26, MD n=12) and the activating receptors NKG2D (HD n=25; MD n=12), NKp46 (HD n=20, MD n=11) and DNAM-1 (HD n=10; MD n=10), in peripheral blood NK cells purified from healthy donors and from melanoma patients. On the right panel, plots depicting the expression of KIR3DL1, KIR2DL3, NKG2D, NKp46 and DNAM-1 according to CD56 expression in NK cells from a representative healthy donor and a representative melanoma patient. All experiments were performed in duplicate.

Journal: Cancer immunology research

Article Title: Reversal of NK cell exhaustion in advanced melanoma by Tim-3 blockade

doi: 10.1158/2326-6066.CIR-13-0171

Figure Lengend Snippet: (A) Graphs compare the expression of the inhibitory receptors KIR3DL1 (HD n=18; MD n=8) and KIR2DL3 (HD n=26, MD n=12) and the activating receptors NKG2D (HD n=25; MD n=12), NKp46 (HD n=20, MD n=11) and DNAM-1 (HD n=10; MD n=10), in peripheral blood NK cells purified from healthy donors and from melanoma patients. On the right panel, plots depicting the expression of KIR3DL1, KIR2DL3, NKG2D, NKp46 and DNAM-1 according to CD56 expression in NK cells from a representative healthy donor and a representative melanoma patient. All experiments were performed in duplicate.

Article Snippet: NK cell enrichment was performed by negative selection using Easy-Sep Human NK cell Enrichment Kit (StemCell Technologies) according to the manufacturer's recommendations, obtaining more than 95% CD3 − CD56 + populations.

Techniques: Expressing, Purification

(A) Graph comparing Tim-3 expression in NK cells from healthy donors (HD; n=45) and melanoma patients (MD; n=41). Represented as the percentage of Tim-3+ cells (left panel) and the MFI of the Tim-3+ population (right panel). (B) The graphs show the percentage (left panel) and MFI (right panel) of Tim-3+ NK cells from healthy donors (n=30) and patients with melanoma stage I (n=47), II (n=18) and III/IV (n=18). All experiments were performed in duplicate.

Journal: Cancer immunology research

Article Title: Reversal of NK cell exhaustion in advanced melanoma by Tim-3 blockade

doi: 10.1158/2326-6066.CIR-13-0171

Figure Lengend Snippet: (A) Graph comparing Tim-3 expression in NK cells from healthy donors (HD; n=45) and melanoma patients (MD; n=41). Represented as the percentage of Tim-3+ cells (left panel) and the MFI of the Tim-3+ population (right panel). (B) The graphs show the percentage (left panel) and MFI (right panel) of Tim-3+ NK cells from healthy donors (n=30) and patients with melanoma stage I (n=47), II (n=18) and III/IV (n=18). All experiments were performed in duplicate.

Article Snippet: NK cell enrichment was performed by negative selection using Easy-Sep Human NK cell Enrichment Kit (StemCell Technologies) according to the manufacturer's recommendations, obtaining more than 95% CD3 − CD56 + populations.

Techniques: Expressing